What caused the volatility in CLB's 2024 EPS results?

The volatility in Core Laboratories' (CLB) 2024 EPS results can be attributed to several factors:

1. **Geopolitical Conflicts and Trade Sanctions**: Core Laboratories faced challenges due to geopolitical conflicts and trade sanctions in regions like Russia, Ukraine, and the Middle East. These factors negatively impacted demand for laboratory services, leading to a decrease in revenue.
2. **Reduced U.S. Land Activity**: The company also experienced reduced U.S. land activity, which directly affected the company's ability to generate revenue from diagnostic services and other operations. This reduction in activity likely contributed to the decline in EPS.
3. **Hurricane-Related Delays**: Completion diagnostic services in the Gulf of Mexico were delayed due to hurricanes, which affected the company's schedule and revenue. Such disruptions can lead to volatility in financial results.
4. **Strategic Investments and Market Conditions**: Core Laboratories continued to invest in technological advancements and international expansion. These strategic moves, while positive in the long term, can sometimes lead to short-term fluctuations in financial performance as the market adjusts to the changes.

In summary, the volatility in CLB's 2024 EPS results was likely a result of a combination of geopolitical tensions, reduced U.S. land activity, hurricane-related delays, and strategic investments, all of which can lead to significant and unpredictable fluctuations in the company's financial performance.